To date, peptide vaccines to protect CD4+ T-cells have received relatively little attention in terms of vaccine design, although these cells are the primary targets of HIV infection and protecting them will inevitably interfere with this infection; such an effect could contribute to protection against the disease, mainly by controlling immune-mediated inflammation and cell activation (Figure 2) [68–70]. Here, CD4 is linked to infection.